Page History

Fill in results and units for rows 6 and 7
Fill in PKCON values for rows 6 and 7
ANMETH is a "record qualifier" according to Model 2.0 so technically we don't need to add the METHOD variable into PP. There would only be one valid value of PPMETHOD anyway = CALCULATION. (Confirm with Fred)
Review suppPP dataset makes sure it looks ok

The example below shows how to represent various PK analysis parameters at multiple dose, steady state condition.

...

Dataset wrap

Name	pp

Rowcaps

Rows 1-3:	Show the "AUC from T1 to T2" measurements for Drug Parent (Row 1), Drug Metabolite 1 (Row 2) and Drug Metabolite 2 (Row 3).
Row 4:	Shows the "Ratio AUC" measurement of Drug Parent to Drug Metabolite 1. Instead of pre-corrdinating "Ratio AUC of Drug Parent over Drug Metabolite 1" all into the PPTEST, PPANMETH is used to describe the numerator (Drug Parent, PPSEQ 1) and the denominator (Drug Metabolite 1, PPSEQ2) values that contribute to the Ratio AUC calculation in PPTEST. This post-coordination approach liberates the PPTEST variable from having to house hyper-specific, pre-coordinated PK parameter values.
Row 5:	Shows the "Ratio AUC" measurement of Drug Parent to Drug Metabolite 2. Instead of pre-corrdinating "Ratio AUC of Drug Parent over Drug Metabolite 2" all into the PPTEST, PPANMETH is used to describe the numerator (Drug Parent, PPSEQ 1) and the denominator (Drug Metabolite 2, PPSEQ3) values that contribute to the Ratio AUC calculation in PPTEST. This post-coordination approach liberates the PPTEST variable from having to house hyper-specific, pre-coordinated PK parameter values.
Rows 6-7:	Show AUC Infinity Obs and AUC Infinity Pred for the DRUG PARENT. Both are calculated using the LIN-LOG TRAPEZOIDAL METHOD which is in PPANMETH.

Dataset2

PPMETHODCALCULATIONCALCULATION

Row	STUDYID	DOMAIN	USUBJID	PPSEQ	PPRFID	PPTESTCD	PPTEST	PPCAT	PPSCAT	PPORRES	PPORRESU	PPSTRESC	PPSTRESN	PPSTRESU	PPSPEC		PPANMETH	PPFAST	PPNOMDY	PPRFTDTC
1	ABC-123	PP	123-1001	1	B2222	AUCINT	AUC from T1 to T2	DRUG PARENT	NCA	154.1	h*ng/L	154.1	154.1	h*ng/L	PLASMA			Y	1	2001-02-01T12:00
2	ABC-123	PP	123-1001	2	B2222	AUCINT	AUC from T1 to T2	DRUG METABOLITE 1	NCA	144.5	h*ng/L	144.5	144.5	h*ng/L	PLASMA			Y	1	2001-02-01T12:00
3	ABC-123	PP	123-1001	3	B2222	AUCINT	AUC from T1 to T2	DRUG METABOLITE 2	NCA	294.7	h*ng/L	294.7	294.7	h*ng/L	PLASMA	CALCULATION		Y	1	2001-02-01T12:00
4	ABC-123	PP	123-1001	4	B2222	RAAUC	Ratio AUC		NCA	1.07		1.07	1.07		PLASMA	CALCULATION	DRUG METABOLITE 1 (PPSEQ 2) TO DRUG PARENT (PPSEQ 1)	Y	1	2001-02-01T12:00
5	ABC-123	PP	123-1001	5	B2222	RAAUC	Ratio AUC		NCA	0.52		0.52	0.52		PLASMA	CALCULATION	DRUG METABOLITE 2 (PPSEQ 3) TO DRUG PARENT (PPSEQ 1)	Y	1	2001-02-01T12:00
6	ABC-123	PP	123-1001	1	B2222	AUCIFO	AUC Infinity Obs	DRUG PARENT	NCA	?	?	?	?	?	PLASMACALCULATION	LIN-LOG TRAPEZOIDAL METHOD	Y	1	2001-02-01T12:00
7	ABC-123	PP	123-1001	2	B2222	AUCIFP	AUC Infinity Pred	DRUG PARENT	NCA	?	?	?	?	?	PLASMACALCULATION	LIN-LOG TRAPEZOIDAL METHOD	Y	1	2001-02-01T12:00

...